Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide for osteoporotic pelvic fracture healing
ACTRN12614000059662Phase 4Terminated
- Sponsor
- Royal Brisbane and Women's Hospital
- Start
- Sep 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of teriparatide in pelvic fracture and osteoporosis (2 arms), sponsored by Royal Brisbane and Women's Hospital. Primary endpoint: Rate of fracture healing on CT scan. Started Sep 2014; status: terminated.
02
Drugs
teriparatide
03
Conditions
pelvic fractureosteoporosis
Beyond the preview
Go deeper on ACTRN12614000059662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000059662.